Amarin Corp Plc (AMRN)

[ziploc_1]

Ns...Amarin could essentially give away the statin and charge only for the Vascepa in a combo for the U.S....The patented combo would present a formidable challenge for the generics to infringe on. I look forward for work on this to now proceed rapidly.

A combo with MND-2119 might even be better....but KM must have had some good reason for not mentioning MND-2119 at the JPM conference yesterday....I'm not sure why we investors should not be privy to this reason....Amarin paid Mochida $2 million at the time of their agreement to share patents, but it might be that Amarin would still have to pay royalties to Mochida for the use of their inventions.